Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164

Untitled work

(1998) · The Journal of Clinical Psychiatry · Cited by 19,139

Untitled work

(1998) · PubMed · Cited by 10,216

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766

Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study

Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.272.22.1749 · Cited by 2,648

Comparison of two methods to detect publication bias in meta-analysis.

Peters, J. L. (2006) · JAMA · doi:10.1001/jama.295.6.676 · Cited by 2,278

Utility of a New Procedure for Diagnosing Mental Disorders in Primary Care: The PRIME-MD 1000 Study

Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.1994.03520220043029 · Cited by 1,873

New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis

Charlson, F., van Ommeren, M., Flaxman, A., Cornett, J., Whiteford, H., & Saxena, S. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30934-1 · Cited by 1,702

Tercer Consenso Argentino sobre el manejo de los Trastornos Bipolares. Tercera parte: Manejo de los Trastornos Bipolares en el contexto de situaciones especiales

Cetkovich, M., Abadi, A. F., Camino, S., Bonetto, G. G., Herbst, L., Marengo, E., Torrente, F. M., Maresca, T., Bustin, J., Morra, C. A., et al. (2023) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i161.488 · Cited by 1

Effects of different doses of esketamine on hemodynamic indexes, pain stress indexes, and VAS scores in patients with benign ovarian tumors undergoing laparoscopic resection induced by remifentanil

(2023) · European Journal of Gynaecological Oncology · doi:10.22514/ejgo.2023.082 · Cited by 1

The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder

Schwartz, O., Amminger, G. P., Baune, B., Bedi, G., Berk, M., Cotton, S., Daglas‐Georgiou, R., Glozier, N., Harrison, B. J., Hermens, D. F., et al. (2023) · Trials · doi:10.1186/s13063-023-07631-3 · Cited by 1

Ketamininfusionstherapie zur Behandlung von Depressionen – Schritt für Schritt

Müller‐Dahlhaus, F., Junginger, M., & Kelsch, W. (2023) · PSYCH up2date · doi:10.1055/a-2089-3960 · Cited by 1

Évolution ou révolution dans le traitement des dépressions avec la kétamine ?

Fossati, P. (2023) · Biologie Aujourd hui · doi:10.1051/jbio/2023023 · Cited by 1

Funcionamiento neurocognitivo en el uso recreativo de la de ketamina: una revisión de alcance

Bellas-Arnosi, C., Holguı́n, S. R., Beranuy, M., & Calvo, F. (2024) · African journal of rhetoric · doi:10.21134/haaj.v24i1.782 · Cited by 1

The Use of Prophylactic Ketamine to Mitigate Postoperative Depressive Symptoms: A Systematic Review

Yip, E., & Fleck, D. A. (2024) · Journal of PeriAnesthesia Nursing · doi:10.1016/j.jopan.2024.05.026 · Cited by 1

Eficácia e segurança da cetamina para o tratamento de depressão unipolar refratária: uma overview de revisões sistemáticas

Gabriela Ribeiro, P. E. N. A., Zonzini, F. H. T., & Bonetti, A. D. F. (2024) · Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde · doi:10.30968/rbfhss.2024.154.1122

A Quantitative and Qualitative Analysis of the Patient and Caregiver’s Perspective on Outcomes of Intravenous Administration of Low-Dose Ketamine for C-PTSD, TBI, and Treatment Resistant MDD: A Clinical Example

Hentig, L., Hentig, J., & Gill, J. (2025) · Reports — Medical Cases Images and Videos · doi:10.3390/reports8010013 · Cited by 1

Comparing Intravenous Racemic Ketamine and Intranasal Esketamine for Treatment-Resistant Depression: A Clinical Dilemma

Singh, B., Voort, J. L. V., & Kung, S. (2025) · Neuromethods · doi:10.1007/978-1-0716-4599-4_13 · Cited by 1

Could R‐Ketamine and Wolfram Syndrome Inform Understanding of Depression and Suicidality? A Sigma‐1 Receptor‐Based Perspective

Kalkman, H. O., & Smigielski, L. (2025) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.70019 · Cited by 1

Pharmakotherapie der Depression – neue Erkenntnisse und neue Strategien

Hullmeine, L., & Bschor, T. (2021) · PiD - Psychotherapie im Dialog · doi:10.1055/a-1215-1756 · Cited by 1

Ketamine for depression – evidence and proposals for practice

Kvam, T.-M., Stewart, L. H., Blomkvist, A. W., & Andreassen, O. A. (2021) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.21.0480 · Cited by 1

Ketamine and Other Glutamate Receptor Antagonists As Fast-Actin

Chen, M., Su, T., & Tsai, S. (2022) · Neuromethods · doi:10.1007/978-1-0716-2083-0_19 · Cited by 1

Ketamine in Psychiatric Disorders

Danyeli, L. V., Götting, F. N., Şen, Z. D., Li, M., & Walter, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_420 · Cited by 1

Interventional psychiatry (Part 1)

Arbuck, D. M. (2023) · Current Psychiatry · doi:10.12788/cp.0356 · Cited by 1

Letter to the editor - Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis

Souza‐Marques, B., Mello, R. P., Jesus‐Nunes, A. P., Correia‐Melo, F. S., Sampaio, A. S., & Quarantini, L. C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.01.026 · Cited by 1

Wider, faster, more: Re-envisioning the treatment and research of depression to address its public health burden in the United StatesPreprint

Lorenzo‐Luaces, L. (2022) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/tzpd2 · Cited by 1

Efficacy and Safety of Repeated Subcutaneous Ketamine Injections for Treatment Resistant Depression - The KADS Study: A Randomised, Double-Blind, Comparator-Controlled TrialPreprint

Loo, C. K. A., Glozier, N., Barton, D., Baune, B. T., Mills, N. T., Fitzgerald, P. B., Glue, P., Sarma, S., Gálvez, V., Hadži-Pavlović, D., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4107711 · Cited by 1

Efficacy and Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPreprint

Gowthami, B., Mehta, I., Baiju, S., Appani, A., Suvarna, T., Randhawa, K., Kakkad, A. M., Syed, A. B., Kumar, V., Ramteke, H. D., et al. (2025) · medRxiv · doi:10.1101/2025.09.22.25336317 · Cited by 2

Ketamine in Psychiatric Disorders

Danyeli, L. V., Götting, F. N., Şen, Z. D., Li, M., & Walter, M. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_420-1 · Cited by 1

Pengaruh Beberapa Media Pembawa terhadap Efektivitas Rhizobium japonicum

Suharjo, U. K. J. (1985)

Bipolar Disorder

(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg002

Psychiatrie

Khazaal, Y., Elowe, J., Klouček, P., Preisig, M., Tadri, M., Vandeleur, C. L., Vandenberghe, F., Verloo, H., Ros, T., & Guntenb, A. V. (2021) · JMIG · doi:10.53738/revmed.2021.17.720-21.0085

Ein paar kritische Gedanken zu intranasalem Esketamin

Spießl, H. (2022) · Der Nervenarzt · doi:10.1007/s00115-022-01359-2

Utilisation de la kétamine en psychiatrie : mise à jour

Clerc, M.-T., Rosenhagen-Lapoirie, M., & von Gunten, A. (2022) · JMIG · doi:10.53738/revmed.2022.18.793.1626

Introductory Chapter: Is Ketamine the New Panacea of the 21st Century?

Sáiz‐Sapena, N., & Granell, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104966

Letter to the editor about “Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis”

Tao, Y., Xu, H., & Huang, X. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.10.013

Long-Term Effects of Ketamine Infusions in Comparison to Combination Therapy involving additional rTMS, Neurofeedback and Psychotherapy - A Retrospective Survey Study of Subjective EffectsPreprint

Kreßner, J., Frank, A., & Scheib, M. H. W. (2023) · doi:10.31219/osf.io/2hc8a

Neue Arzneimittel 2021

Hein, L., & Seifert, R. (2022) · Springer eBooks · doi:10.1007/978-3-662-66303-5_2

Schnell wirksame Antidepressiva

Şen, Z. D., Danyeli, L. V., & Walter, M. (2022) · Springer eBooks · doi:10.1007/978-3-662-65734-8_10

Drug discovery: Standing on the shoulders of giants

Miller, S. M., Moos, W. H., Munk, B. H., Munk, S. A., Hart, C. P., & Spellmeyer, D. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824304-6.00001-8

Psychedelics as psychiatric medicines: Current challenges and future prospects

Castle, D. J., Ledwos, N., & Nutt, D. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780192863607.003.0011

Biweekly vs Triweekly low dose intravenous ketamine acute series for severe major depression: A case report

Hernandorena, C. V., Gilmar, G., Casimiro, C. A., & Vázquez, G. H. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100620

Is this for real?

Mikellides, G. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20230911gm

Better than we Think: Is the Treatment of Depressed Patients More Effective than we Think?

Zimmerman, M. A., & Lin, S.-Y. (2023) · Annals of Clinical Psychiatry · doi:10.12788/acp.0117

Sex Differences in the Antidepressant Effects of Ketamine

Myers, M. (2023) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2023-15485

Efficacy of Ketamine Therapy in the Treatment of Refractory Major Depressive Disorder

van Oers, H. (2023) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2023.00023

Ketamine Cystitis in a Female Patient on Short-term Ketamine Therapy for Treatment Resistant Depression: Case Report (Preprint)Preprint

Chang, M. (2023) · doi:10.2196/preprints.50901

Attenuation of severe ketamine-induced neuropsychiatric side effects by lamotrigine in a patient with treatment resistant bipolar depression: A case report

Barnett, B. S., & Anand, A. (2023) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2023.100167 · Cited by 1

Sub-anaesthetic doses of Esketamine ameliorate memory impairment in Alzheimer's disease by regulating the BDNF/AKT/mTOR signaling pathway in ratsPreprint

Wang, C., Xu, F., Yu, X., Yang, J., Guo, D., & Gan, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3687417/v1

Ketamine and Nitrous Oxide

Janski, A. M., Hristidis, V. C., Zorumski, C. F., & Conway, C. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00064-6

The Role of Rapid-Acting Antidepressants in Suicidal Crisis Management

Lengvenytė, A., Sarchiapone, M., Iosue, M., & Courtet, P. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009067287.016

Using Interventional Pharmacoeconomic Clinical Trials and Outcomes-Based Contracts to Repurpose Generic Drugs with Cost-SavingsPreprint

Kerdemelidis, S. (2024) · doi:10.58647/drugarxiv.pr000008.v1

Escetamina intranasal no manejo da depressão resistente ao tratamento em paciente com história de negligência emocional na infância

Weber, C. A. T., Périco, C. D. A.-M., & Ismael, F. (2024) · Debates em Psiquiatria · doi:10.25118/2763-9037.2024.v14.1201

Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)

Singh, S. D. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108623872.001

Using Interventional Pharmacoeconomic Clinical Trials and Outcomes-Based Contracts to Repurpose Generic Drugs with Cost-SavingsPreprint

Kerdemelidis, S. (2024) · doi:10.58647/drugarxiv.pr000008.v4

Using Interventional Pharmacoeconomic Clinical Trials and Outcomes-Based Contracts to Repurpose Generic Drugs with Cost-SavingsPreprint

Kerdemelidis, S. (2024) · doi:10.58647/drugarxiv.pr000008.v3

Pain in Seriously Mental Ill Populations

Owen‐Smith, A. A., & Scherrer, J. F. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197649176.003.0022

Results of esketamine administration in a Greek population; a case series

Fotiadis, P., Tsalkitzi, E., Dimellis, D., Rantis, K., Tsimpiris, A., & Pagkalos, G. (2024) · Psychiatriki · doi:10.22365/jpsych.2024.006 · Cited by 1

Neuromodulation Therapies

Burhan, A. M., Goveas, D., Thiab, S., & Blair, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-53976-3_14

Are ketamine and its enantiomers the answer to treatment-refractory depression?

Belge, J.-B., Scantamburlo, G., & Constant, E. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2373302

Diretrizes da Associação Brasileira de Psiquiatria para o manejo do comportamento suicida: intervenção

Baldaçara, L., Périco, C. D. A.-M., Pinto, F. I., Grüdtner, R. R., Calfat, E. L. D. B., da Rocha, G. A., Porto, D. M., Leite, V. D. S., Robis, K. P., Fidalgo, T. M., et al. (2024) · Debates em Psiquiatria · doi:10.25118/2763-9037.2024.v14.1262

Chapter 21. Ketamine and Esketamine

Mathai, D. S., & Mathew, S. J. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as21

Assessing the Efficacy of Methods for Treatment-Resistant Depression: A Review

Crisan, Z. (2024) · Journal of Student Research · doi:10.47611/jsrhs.v13i1.6275

Terapijski rezistentna depresija: nove spoznaje u etiopatogenezi i uloga esketamina u liječenju

Živković, M., Žujić, D., & Mihaljević-Peleš, A. (2024) · Socijalna psihijatrija · doi:10.24869/spsih.2024.151

Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta‐analyses of randomized controlled trials

Terao, I., & Kodama, W. (2024) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70042

Repeated intravenous infusions of esketamine in inpatients with bipolar depression: A retrospective real-world study

Shire, N. G., Ioannou, M., Falk, Ö., Wold, A. B., Wass, C., Szabó, Z., & Steingrímsson, S. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100870

Anhedonia: a unifying symptom and a transdiagnostic therapeutic target

Rosso, G., Pesci, N. R., PERACCHIA, S., Garrone, C., Salvo, G. D., & Maina, G. (2025) · Minerva Psychiatry · doi:10.23736/s2724-6612.24.02572-7

Bipolar Disorder

(2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg002.pub2

Ketamine

Ramm, R., Wiisanen, M., & DeMarco, M. (2025) · Psychedelics in Palliative Care · doi:10.1093/med/9780197760864.003.0005

Ketamine - mechanisms of action as an antidepressant

Gębik, B., Bliźniewska-Kowalska, K. M., & Gałecki, P. (2025) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/202128

Sex differences in placebo and antidepressant response to intranasal esketamine for treatment-resistant depression: a pooled participant analysis of randomized controlled trialsPreprint

Huc, M., Siddiqi, S., Myers, M., Colman, I., Salmaso, N., Jaworska, N., & Aguilar‐Valles, A. (2025) · medRxiv · doi:10.1101/2025.06.26.25330356

Anesthetic Amnesia: The Forgotten Importance of Forgetting?

Pryor, K. O., Jiang, Y., & SLEIGH, J. W. (2025) · Anesthesiology · doi:10.1097/aln.0000000000005544

Troubles bipolaires et risque suicidaire

Lengvenytė, A., & Courtet, P. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77180-4.00028-7

Key Considerations for Practical Administration of Ketamine in Severe Depression, and Its Use in Community Care in Edmonton, AB, Canada

Chrenek, C., & Swainson, J. (2025) · Neuromethods · doi:10.1007/978-1-0716-4599-4_12

Ketamine/esketamine for treatment-resistant depression

Nikayin, S., & Sanacora, G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00013-x · Cited by 3

Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review

Hughes, B., Mirza, S., Ponamala, M., Sagaser, J., Paredes, R., Hematillake, N., Tailor, C., Khan, R., & Pemminati, S. (2025) · Cureus · doi:10.7759/cureus.90425

Re-evaluating Ketamine Delivery Modalities in Treatment-Resistant-Depression: Opportunities Beyond Intravenous Use

Kainat, K., & Raza, M. A. (2025) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000002035

Preclinical Studies on Ketamine and Its Enantiomers with Translational Significance

Elersič, K. (2025) · Neuromethods · doi:10.1007/978-1-0716-4603-8_5

Human in vivo assessment of ketamine binding of the serotonin transporter—follow up at a higher dose

Schlosser, G., Murgaš, M., Godbersen, G. M., Reichel, S., Silberbauer, L., Nics, L., Winkler, D., Stimpfl, T., Hacker, M., Kasper, S. F., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1651016

Is intranasal esketamine versus intravenous ketamine a therapeutic innovation or a divide in access to care?

Benhaddouch, Y., & Ammouri, A. E. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.10.005

Ketamine for depression and other psychiatric diseases

Roth, W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29930-8.00005-9

Intranasal esketamine for depression: Transforming psychiatric treatment or a temporary solution?

Cartas, N., Dăscălescu, I., Neaga, A., Păun, M. L., & Petriuc, A. F. (2025) · Bulletin of Integrative Psychiatry · doi:10.36219/bpi.2025.3.07

Chapter 9. Club Drugs and Inhalants

Rosenthal, R. N., & Tsoy-Podosenin, M. (2025) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894550862.lg09

Ketamine enantiomers and the gut microbiota: mechanisms, clinical implications, and future directions

Xie, J.-X., & Zhou, L.-W. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11357-7

Efficacy and Safety of Intravenous Esketamine in Elderly Patients Undergoing Laparoscopic Radical Prostatectomy

Zhang, T., Yan, S., Wang, H., & Wang, L. (2026) · Journal of Visualized Experiments · doi:10.3791/69250

Ketamine Combined With Psychotherapy as a Treatment for Resistant Depression in a Public European Hospital

da Silva, F. A., Avelar, R. S., Peixoto, B., Bacelar–Nicolau, L., Santos, F., Ribeiro, J. C., & Heitor, M. J. (2026) · Brain and Behavior · doi:10.1002/brb3.71164

II Encuentro presencial de la red de programas de doctorado en Ciencias de la Salud

Montaño, V. S., Leiva, M. G., & Landa, S. U. (2026) · Universidad de Burgos eBooks · doi:10.36443/9791387585273

Predictors of responsiveness to ketamine: An updated systematic review of neuroimaging findings.

Kiani, I., Cattarinussi, G., Sambataro, F., Schiena, G., Delvecchio, G., & Squarcina, L. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121521

Ketamine in clinical psychiatry and addictology - a narrative review

Vašíček, O., & Páleníček, T. (2026) · Psychiatrie pro praxi · doi:10.36290/psy.2026.004

Antidepressants

Duncan, E., Hersant, H., & Khairova, R. A. (2026) · Springer eBooks · doi:10.1007/978-3-032-15772-0_4

Treatment of Depression in Mild Cognitive Impairment: Is There a Role for Ketamine?

Flint, A. J. (2026) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2026.03.244

Exploring the molecular determinants of behavioral changes induced by ketamine at the nanoscale

Uyttersprot, F. (2024) · theses.fr (ABES) · doi:10.70675/df438baaz92d0z488aza38cz4227b46c9acb

Comparison of average time-to-relapse following ECT versus ketamine – A systematic review

Chang, M., Young, A. H., & Juruena, M. F. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261430502 · Cited by 1

Protocol and pilot results for a double-blind randomized placebo-controlled trial of ketamine under propofol sedation for chronic pain and depression

Lii, T. R., Sikka, P., Deverett, B., Altirkawi, O. K., & Heifets, B. D. (2026) · Pain Management · doi:10.1080/17581869.2026.2658080

Esketamine Exposure Affects Neurodevelopment and Glutamate‐NMDAR Signaling in Zebrafish Larvae

Wang, J., Huang, S., Lin, T., Fu, Z., Zuo, Z., Chen, Z. F., & He, C. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70839

Intranasal Ketamine for Existential Distress in Advanced Cancer

Aguiar, S., Makarious, M., Lipsitz, O., deVries, F. E., Doyle, Z., McIntyre, R. S., Rodin, G., Zimmermann, C., Mak, E., Hannon, B. L., et al. (2026) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2026.04.611 · Cited by 1

Distinct therapeutic profiles of ketamine in treatment-resistant depression: an exploratory analysis

Liu, K.-W., Lin, W., Li, C., Bai, Y., Su, T., & Chen, M. (2026) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyag021

Phytochemical heterocycles in depression management: A sustainable strategy

Kaur, H., & Kaur, T. (2026) · Scripta Medica · doi:10.5937/scriptamed57-60299

Efficacy and Safety of Adjunctive Therapy Using Single High-Dose S-Ketamine Infusion for Fibromyalgia: A Multicenter, Prospective, Randomized, Controlled, Open-Label, Blinded-Endpoint Study Protocol

Shrestha, N., Liu, M. M., 牛少宁, Cheng, H., Sun, Y., Mei, S., & Luo, F. (2026) · Journal of Pain Research · doi:10.2147/jpr.s598907 · Cited by 1

ЕВОЛЮЦІЯ КЕТАМІНУ: ВІД ДИСОЦІАТИВНОГО АНЕСТЕТИКА ДО ШВИДКОДІЮЧОГО АНТИДЕПРЕСАНТА ТА НОВИХ ТЕРАПЕВТИЧНИХ ГОРИЗОНТІВ

Чорномидз, А. В. (2026) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2026.v.i1.16129

References

(2024) · doi:10.1176/appi.books.9798894551944.bm01

Efficacy and safety of perioperative esketamine in improving postoperative sleep disturbances: A systematic review and meta-analysis

Yang, X., Gao, T. Y., Wang, S. Y., Hu, L., Huang, F., Cui, W., & Zhang, L. (2026) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2026.112246

Considerations on the pharmacological approach of the Latin American consensus on treatment-resistant depression

Montero, A. A. (2026) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.sjpmh.2026.03.007

Bipolar affective disorder: a review of current trends and new therapeutic perspectives

Kawecki, M., Chrystofiak, J. M., Banasik, W. P., Zaworska, J. L., Urban, T. J., Chajęcki, P., Dydoń-Pikor, M., & Baran, F. (2026) · Humanities & Social Sciences Reviews · doi:10.18510/hssr.2026.14121

Sustained pharmacodynamic effects of S‐ketamine on cortical excitability and resting‐state brain activity: A randomized, placebo‐controlled trial

de Cuba, C. M. K. E., de Goede, A. A., van Mechelen, J., Borghans, L. G. J. M., Aa, L., Olofsen, E., Juachon, M. J., Doll, R. J., Gillespie, A., Harmer, C. J., et al. (2026) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70649

Efficacy and safety of perioperative esketamine for postoperative depressive symptoms in breast cancer patients: a meta-analysis

Ji, R., Shi, X., Liu, X. Q., Xiao, H., Sun, X., Yu, S., Dong, G., Zheng, C., & Ji, F. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1806943

Real-world outcomes of intranasal esketamine and intravenous ketamine induction therapy for treatment-resistant depression in a community clinic: a retrospective cohort study

Bellanti, P. A., Lewis, J., Seifferth, B., & Adams, D. Z. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1867963

Ketamine in Modern Medicine

Schwenk, E. S., Graff, V., Malone, B., & Bloom, R. (2026) · Advances in Anesthesia · doi:10.1016/j.aan.2026.06.007

Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis

Bahji, A., Zarate, C. A., & Vázquez, G. H. (2022) · Figshare · doi:10.6084/m9.figshare.19336304

Ketamine for the treatment of major depression: a systematic review and meta-analysis

Nikolin, S., Rodgers, A., Schwaab, A., Bahji, A., Zarate, C. A., Vázquez, G. H., & Loo, C. K. A. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102127 · Cited by 191

Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis

Seshadri, A., Prokop, L. J., & Singh, B. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.137 · Cited by 55

Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis

Elmosalamy, A., Tarikogullari, I., Patarroyo-Rodríguez, L., Wilson, G., Voort, J. L. V., Kung, S., Frye, M. A., & Singh, B. (2025) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253251394127 · Cited by 14

Comparative study of esketamine and racemic ketamine in treatment-resistant depression

Correia‐Melo, F. S., Leal, G. C.-G., Carvalho, M. S., Jesus‐Nunes, A. P., Ferreira, C. B., Vieira, F., Magnavita, G. M., Vale, L. A. S., Mello, R. P., Nakahira, C., et al. (2018) · Medicine · doi:10.1097/md.0000000000012414 · Cited by 61